Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Trials|November 15, 2024
The BrEasT cancer afTER-CARE (BETTER-CARE) programme to improve breast cancer follow-up: design and feasibility study results of a cluster-randomised complex intervention trialAnna Horn, Julia Wendel, Isabella Franke, et al.
Chemical Science|January 13, 2022
Total synthesis and mechanism of action of the antibiotic armeniaspirol ANanaji Arisetti, Hazel L S Fuchs, Janetta Coetzee, et al.
Tuberculosis (Edinburgh, Scotland)|August 25, 2016
Micrococcin P1 - A bactericidal thiopeptide active against Mycobacterium tuberculosisGiulia Degiacomi, Yoann Personne, Guillaume Mondésert, et al.
JMIR Research Protocols|May 26, 2025
ENABLE-App-Based Digital Capture and Intervention of Patient-Reported Quality of Life, Adverse Events, and Treatment Satisfaction in Breast Cancer: Protocol for a Randomized Controlled TrialThomas M Deutsch, Léa L Volmer, Manuel Feisst, et al.
JMIR Research Protocols|June 11, 2025
Correction: ENABLE-App-Based Digital Capture and Intervention of Patient-Reported Quality of Life, Adverse Events, and Treatment Satisfaction in Breast Cancer: Protocol for a Randomized Controlled TrialThomas M Deutsch, Léa L Volmer, Manuel Feisst, et al.
Mayo Clinic Proceedings. Digital Health|October 6, 2025
A Standardized Temporal Segmentation Framework and Annotation Resource Library in Robotic SurgeryBusisiwe Mlambo, Mallory Shields, Simon Bach, et al.
Archives of Gynecology and Obstetrics|January 20, 2026
First trimester prediction of gestational diabetes mellitus by machine learning in twin pregnanciesYoram Louzoun, Tamar Michelson, Mar Bennasar, et al.
Fetal Diagnosis and Therapy|January 2, 2026
Preeclampsia prediction by machine learning in twin pregnanciesHamutal Meiri, Elisa Bevilacqua, Nadav Kugler, et al.
Neuro-Oncology Practice|May 13, 2024
App-based assessment of patient-reported outcomes in the Molecular Tumor Board in the Center for Personalized Medicine-(TRACE)Lorenz Dörner, Lucia Grosse, Felix Stange, et al.
Science (New York, N.Y.)|June 6, 2015
Antibiotics. Targeting DnaN for tuberculosis therapy using novel griselimycinsAngela Kling, Peer Lukat, Deepak V Almeida, et al.
Pageof 7